Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00035024.xml
Download PDF
Thromb Haemost 2006; 95(05): 915-916
DOI: 10.1160/TH05-12-0824
DOI: 10.1160/TH05-12-0824
Letters to the Editor
Venous thrombosis is not increased in younger women on genuine oestrogen postmenopausal hormonal replacement therapy: Results from the Danish Osteoporosis Prevention Study (DOPS)
Financial support: The Danish Osteoporosis Prevention Study is financially supported by grants from the Karen Elise Jensen Foundation and from Novo Nordisk Farmaka (Lyngby, Denmark). The present investigation was supported by grants from the Danish Research Council, the Danish Heart Foundation (98–1–61–22501; B. & O. Rüditz-Larsen forskningsfond), the Institute of Clinical Research Odense University, the Faculty of Health Sciences Odense University and Overlægerådets legat Odense University Hospital.
Further Information
Publication History
Received
27 December 2006
Accepted after revision
26 March 2006
Publication Date:
01 December 2017 (online)
-
References
- 1 Daly E, Vessey MP, Hawkins MM. et al. Risk of venous thromboembolism in users of hormone replacement therapy. Lancet 1996; 348: 977-80.
- 2 Jick H, Derby LE, Myers MW. et al. Risk of hospital admission for idiopathic venous thromboembolism among users of postmenopausal oestrogens. lancet 1996; 348: 981-3.
- 3 Daly E, Vessey MP, Painter R. et al. Case-control study of venous thromboembolism risk in users of hormone replacement therapy. Lancet 1996; 348: 1027.
- 4 Grodstein F, Stampfer MJ, Goldhaber J. et al. Prospective study of exogenous hormones and risk of pulmonary embolism in women. Lancet 1996; 348: 983-7.
- 5 Perez SGutthann, Garcia LARodriguez, Castellsague J. et al. Hormone replacement therapy and risk of venous thromboembolism: population based case-control study. BMJ 1997; 314: 796-800.
- 6 Grady D, Wenger NK, Herrington D. et al. Postmenopausal hormone therapy increases risk for venous thromboembolic disease. Ann Int Med 2000; 132: 689-96.
- 7 Writing group for the Women’s Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. JAMA 2002; 288: 321-33.
- 8 The Women’s Health Initiative Steering Committee. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy. JAMA 2004; 291: 1701-12.
- 9 Høibraaten E, Abdelnoor M, Sandset PM. Hormone replacement therapy with estradiol and risk of venous thromboembolism. Thromb Haemost 1999; 1218-21.
- 10 Mosekilde L, Hermann AP, Beck-Nielsen H. et al. The Danish osteoporosis prevention study (DOPS): project design and inclusion of 2000 normal perimenopausal women. Maturitas 1999; 31: 207-19.